Retrospective Analysis of Neutrophil-to-Lymphocyte Ratio in Patients with Melanoma Who Received Ipilimumab Monotherapy or Ipilimumab in Combination with Nivolumab in Japan.
Biol Pharm Bull
; 46(3): 427-431, 2023.
Article
in En
| MEDLINE
| ID: mdl-36858571
Full text:
1
Database:
MEDLINE
Main subject:
Nivolumab
/
Melanoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Biol Pharm Bull
Journal subject:
BIOQUIMICA
/
FARMACOLOGIA
Year:
2023
Type:
Article